Low employee moral at Merck. - Avis employé Employé (anonyme) Merck

3,0
16 janv. 2009
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent values and principles that really point the direction leaders must follow. Excellent compensation and genuine interest in continuous improvement in all aspects of the business. Need for change is clear in leaders' minds. Flexibility and customer focus being valued more as it is enforced within the new culture. More frequent communication and webcasts by Senior Corporate Management through e-mails and web casts as compared to previous CEO. More open culture approaching a risk-taking attitude. Work/life balance is very much emphasized and encouraged among all employees.

Inconvénients

Hysterical downsizing. Lack of judgement and appreciation for people that really get the job done. Favoritism. Aristocratic and dictatorial style by local senior management not allowing true challenging of the status quo. Works like a Company surrounded by mirrors with appreciation of outside world. Arrogant style. Lack of authenticity. Full pipeline but no quantifiable results.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout